作者
Prasad T. Oommen,Timmy Strauß,Karen Baltruschat,Ivan Foeldvari,Christoph Deuter,Gerd Ganser,Johannes‐Peter Haas,Claas Hinze,Dirk Holzinger,Anton Hospach,Hans-Iko Huppertz,Arnold Illhardt,Michael E. Jung,Tilmann Kallinich,Ariane Klein,Kirsten Minden,Kirsten Mönkemöller,S. Mrusek,Ulrich Neudorf,Gregor Dückers,Tim Niehues,Matthias Schneider,Philipp Schoof,A. Thon,Michael Wachowsky,Norbert Wagner,Susanne Bloedt,Michaël Hofer,Klaus Tenbrock,Catharina Schuetz
摘要
New therapeutic strategies for juvenile idiopathic arthritis (JIA) have evolved within the past ten years, and as a result, an update of the 2011 recommendations of the German management guidelines was initiated.A systemic literature review was performed, overarching principles were proposed and pre-selected via an online survey followed by two multidisciplinary consensus conferences. Pharmacological and non-pharmacological treatments were discussed, statements were proposed and ultimately agreed upon by nominal group technique (NGT).12 overarching therapeutic principles, as well as 9 recommendations on pharmacological and 5 on non-pharmacological treatments for JIA were agreed upon.This report summarizes the recent update of the interdisciplinary, consensus-based German guidelines on the management of JIA. The multi- and interdisciplinary participation of all caregivers was central for this patient-focused update. With these guidelines, physicians can choose an evidence-based approach, which allows better tailored treatment in this vulnerable cohort of children and adolescents.